Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.20.2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Revenues $ 5,769 $ 4,727 $ 11,536 $ 9,221
Cost of revenues 3,267 2,552 6,779 4,753
Gross profit 2,502 2,175 4,757 4,468
Operating expenses        
Research and development (85) 270 391 608
Selling, general and administrative 2,418 3,192 4,862 6,918
Total operating expenses 2,333 3,462 5,253 7,526
Income (loss) from operations 169 (1,287) (496) (3,058)
Interest expense (4) (2) (6) (12)
Interest income 8 42 10 84
Other (expense) income, net (77) (41) (197) (100)
Gain on sale of assets 55 0 132 2,472
Income (loss) from continuing operations 151 (1,288) (557) (614)
Income (loss) from discontinued operations (Note 4) (31) 85 917 126
Net income (loss) $ 120 $ (1,203) $ 360 $ (488)
Net income (loss) per share: basic        
Continuing operations $ 0.08 $ (0.98) $ (0.29) $ (0.47)
Discontinued operations: (0.02) 0.06 0.48 0.1
Net income per share: basic 0.06 (0.92) 0.19 (0.37)
Net income (loss) per share: diluted        
Continuing operations 0.07 (0.98) (0.26) (0.47)
Discontinued operations: (0.01) 0.06 0.43 0.1
Net income per share: diluted $ 0.06 $ (0.92) $ 0.17 $ (0.37)
Weighted-average number of shares used in per common share calculations: basic 2,008 1,317 1,924 1,317
Weighted-average number of shares used in per common share calculations: diluted 2,159 1,317 2,118 1,317
Other comprehensive income (loss)        
Net income (loss) $ 120 $ (1,203) $ 360 $ (488)
Foreign currency translation adjustments 188 (163) 355 (96)
Comprehensive income (loss) $ 308 $ (1,366) $ 715 $ (584)